Literature DB >> 27070227

Corneal Stromal Demarcation Line Depth Following Standard and a Modified High Intensity Corneal Cross-linking Protocol.

George D Kymionis, Konstantinos I Tsoulnaras, Dimitrios A Liakopoulos, Christina A Skatharoudi, Michael A Grentzelos, Nikolaos G Tsakalis.   

Abstract

PURPOSE: To compare the corneal stromal demarcation line depth using anterior segment optical coherence tomography (AS-OCT) after corneal cross-linking (CXL) using two different treatment protocols: the standard Dresden protocol (30 minutes with 3 mW/cm(2)) and a modified high intensity protocol (7 minutes with 18 mW/cm(2)), corresponding to a total surface dose of 5.4 and 7.5 J/cm(2), respectively.
METHODS: This prospective, comparative, interventional case series included 29 keratoconic patients (32 eyes). All patients underwent CXL using the same high intensity ultraviolet-A (UV-A) irradiation device (CCL-365; Peschke Meditrade GmbH, Huenenberg, Switzerland). Sixteen eyes were treated for 30 minutes with 3 mW/cm(2) according to the standard Dresden protocol, whereas 16 eyes were treated with a novel modified high intensity CXL protocol for 7 minutes with 18 mW/cm(2) of UV-A irradiation intensity. One month postoperatively, corneal stromal demarcation line depth was measured by two independent observers using AS-OCT.
RESULTS: There was no significant difference in corneal stromal demarcation line depth between observer measurements for both groups (P = .645, Dresden protocol group; P = .715, high intensity group). Mean corneal stromal demarcation line depth was 341.81 ± 47.02 µm for the Dresden protocol group and 313.37 ± 48.85 µm for the high intensity protocol group. There was no statistically significant difference (P = .104) in the corneal stromal demarcation line depth between the two groups. Mean endothelial cell density did not change significantly in either group (P = .090, Dresden protocol group; P = .103, high intensity group). No intraoperative or postoperative complications were noted.
CONCLUSIONS: Corneal stromal demarcation line depth using UV-A irradiance with 3 mW/cm(2) for 30 minutes and 18 mW/cm(2) for 7 minutes was similar. It seems that the current modified accelerated CXL protocol provided the same treatment depth as the standard Dresden protocol. Copyright 2016, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27070227     DOI: 10.3928/1081597X-20160216-01

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  11 in total

Review 1.  New perspectives in keratoconus treatment: an update on iontophoresis-assisted corneal collagen crosslinking.

Authors:  Paolo Vinciguerra; Alessio Montericcio; Fiammetta Catania; Giovanni Fossati; Raffaele Raimondi; Emanuela Filomena Legrottaglie; Riccardo Vinciguerra
Journal:  Int Ophthalmol       Date:  2021-02-16       Impact factor: 2.031

2.  Systematic review and Meta-analysis comparing modified cross-linking and standard cross-linking for progressive keratoconus.

Authors:  Yang Liu; Yi Liu; Ying-Nan Zhang; Ai-Peng Li; Jing Zhang; Qing-Feng Liang; Ying Jie; Zhi-Qiang Pan
Journal:  Int J Ophthalmol       Date:  2017-09-18       Impact factor: 1.779

Review 3.  Current perspectives on corneal collagen crosslinking (CXL).

Authors:  Sandeepani K Subasinghe; Kelechi C Ogbuehi; George J Dias
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-06       Impact factor: 3.117

4.  Accelerated versus standard corneal cross linking in the treatment of ectasia post refractive surgery and penetrating keratoplasty: a medium term randomized trial.

Authors:  Hany A Khairy; Moataz F Elsawy; Khaled Said-Ahmed; Marwa A Zaki; Sameh S Mandour
Journal:  Int J Ophthalmol       Date:  2019-11-18       Impact factor: 1.779

Review 5.  Keratoconus Treatment Algorithm.

Authors:  Konstantinos D Andreanos; Kate Hashemi; Myrsini Petrelli; Konstantinos Droutsas; Ilias Georgalas; George D Kymionis
Journal:  Ophthalmol Ther       Date:  2017-07-28

6.  Multipoint assessment of demarcation line depth after standard and accelerated cross-linking in central and inferior keratoconus.

Authors:  Soheila Asgari; Hassan Hashemi; Fedra Hajizadeh; Mohammad Miraftab; Mohammad Amin Seyedian; Kazem Amanzadeh; Shiva Mehravaran; Akbar Fotouhi
Journal:  J Curr Ophthalmol       Date:  2018-02-14

Review 7.  Corneal stromal demarcation line after collagen cross-linking in corneal ectatic diseases: a review of the literature.

Authors:  Leopoldo Spadea; Emanuele Tonti; Enzo Maria Vingolo
Journal:  Clin Ophthalmol       Date:  2016-09-19

Review 8.  Recent advances in corneal collagen cross-linking.

Authors:  Gitansha Shreyas Sachdev; Mahipal Sachdev
Journal:  Indian J Ophthalmol       Date:  2017-09       Impact factor: 1.848

Review 9.  Patient selection for corneal collagen cross-linking: an updated review.

Authors:  Virgilio Galvis; Alejandro Tello; Alvaro I Ortiz; Luis C Escaf
Journal:  Clin Ophthalmol       Date:  2017-04-07

10.  A Prospective, Comparative, Clinical Study to Evaluate the Safety and Efficacy of Two Different 0.1% Riboflavin Solutions Used in Collagen Crosslinking Treatment for Patients with Keratoconus.

Authors:  Sheetal Brar; Sri Ganesh; Shilpa S Reddy; Nagesh Bn; Dhwni Shahanand
Journal:  Clin Ophthalmol       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.